For all media enquiries please contact:
Jannette Cotterell
Executive Counsel Australia
0419 204 059
jcotterell@executivecounsel.com.au
Archived Media Releases
For copies of all archived media releases dating back to 2009 please contact our office via the ‘contact us’ field on this website.
Background:
The Generic and Biosimilar Medicines Association (GBMA) is the national association representing companies that manufacture, supply and export generic medicines. The generic medicines sector is a high value-add sector delivering significant health and economic benefits to the Australian public.
The availability of generic medicines in this country helps to deliver:
- timely access to affordable medicines; substantial savings to the Pharmaceutical Benefit Scheme;
- thousands of highly skilled jobs; and domestic manufacturing and exports of over $500 million
Generic medicines deliver exactly the same health benefit to all Australians as the original brand and they must meet the same strict Australian standards, including the same manufacturing requirements, as branded medicines.